These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 25025961)
1. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients. Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961 [TBL] [Abstract][Full Text] [Related]
2. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma. Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169 [TBL] [Abstract][Full Text] [Related]
4. HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression. Song J; Wang T; Xu W; Wang P; Wan J; Wang Y; Zhan J; Zhang H Cancer Lett; 2018 Jul; 426():63-72. PubMed ID: 29654889 [TBL] [Abstract][Full Text] [Related]
5. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer. Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996 [TBL] [Abstract][Full Text] [Related]
6. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier. Zheng H; Li C; Li Z; Zhu K; Bao H; Xiong J; Liang P Aging (Albany NY); 2020 Dec; 13(4):4999-5019. PubMed ID: 33411683 [TBL] [Abstract][Full Text] [Related]
7. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6. Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418 [TBL] [Abstract][Full Text] [Related]
8. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling. Qu J; Li M; An J; Zhao B; Zhong W; Gu Q; Cao L; Yang H; Hu C Int J Oncol; 2015 Dec; 47(6):2141-52. PubMed ID: 26459797 [TBL] [Abstract][Full Text] [Related]
10. HOXB9 promotes endometrial cancer progression by targeting E2F3. Wan J; Liu H; Feng Q; Liu J; Ming L Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers. Jang TJ; Jeon KH; Jung KH Yonsei Med J; 2009 Dec; 50(6):818-24. PubMed ID: 20046424 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429 [TBL] [Abstract][Full Text] [Related]
13. HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells. Sha L; Dong L; Lv L; Bai L; Ji X Clin Exp Med; 2015 Feb; 15(1):55-64. PubMed ID: 25081022 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein inhibits expression of N-cadherin and ZEB-1 in murine colon adenocarcinoma. Kudo S; Saito H; Motoyama S; Sasaki T; Imai K; Konno H; Takashima S; Atari M; Sato Y; Minamiya Y Tumour Biol; 2015 Sep; 36(9):7035-43. PubMed ID: 25864110 [TBL] [Abstract][Full Text] [Related]
15. HOXB9 induction of mesenchymal-to-epithelial transition in gastric carcinoma is negatively regulated by its hexapeptide motif. Chang Q; Zhang L; He C; Zhang B; Zhang J; Liu B; Zeng N; Zhu Z Oncotarget; 2015 Dec; 6(40):42838-53. PubMed ID: 26536658 [TBL] [Abstract][Full Text] [Related]
16. The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4. Zhang W; Hu Y; Zhang W; Yi K; Xu X; Chen Z J Immunol Res; 2022; 2022():9385820. PubMed ID: 35692499 [TBL] [Abstract][Full Text] [Related]
17. Homeobox B9 Promotes Colon Cancer Progression by Targeting SRSF3. Yuan L; Cheng F; Wu Z; Li X; Shen W Dig Dis Sci; 2023 Aug; 68(8):3324-3340. PubMed ID: 37258980 [TBL] [Abstract][Full Text] [Related]
18. Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF- Bai L; Ge P; Zhang Y; Song Y; Xing R; Zhou D Biomed Res Int; 2022; 2022():1080315. PubMed ID: 36158877 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma. Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699 [TBL] [Abstract][Full Text] [Related]
20. miR-557 suppressed the malignant behaviours of osteosarcoma cells by reducing HOXB9 and deactivating the EMT process. Wang Y; Hao W; Wang H Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):230-239. PubMed ID: 33666541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]